(Q41189329)

28 September 2017

1 reference

title

Antithymocyte immunoglobulin in severe aplastic anemia and bone marrow transplantation (English)

1 reference

28 September 2017

1 reference

C Colby

1

1 reference

28 September 2017

C A Stoukides

series ordinal

2

1 reference

28 September 2017

T R Spitzer

series ordinal

3

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Annals of Pharmacotherapy

28 September 2017

published in

1 reference

28 September 2017

volume

30

1 reference

28 September 2017

issue

10

1 reference

28 September 2017

page(s)

1164-1174

1 reference

Aplastic Anemia: Biology and Treatment

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Stimulatory serum factors in aplastic anaemia. II. Prognostic significance for patients treated with high dose immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Treatment of adults with severe aplastic anemia: Primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Aplastic anaemia: pathogenetic mechanisms and treatment with special reference to immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Severe aplastic anaemia: the patient without a HLA-identical sibling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

Lymphocytes from multi-transfused patients exhibit cytotoxicity against autologous cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001016

10.1177/106002809603001016

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference